檢索結果 - Sarah Farooq
- Showing 1 - 3 results of 3
-
1
Phase I dose escalation study of the PI3kinase pathway inhibitor BKM120 and the oral poly (ADP ribose) polymerase (PARP) inhibitor olaparib for the treatment of high-grade serous o... 由 Ursula A. Matulonis, Gerburg M. Wulf, William T. Barry, Michael J. Birrer, Shannon N. Westin, Sarah Farooq, K.M. Bell-McGuinn, Elizabeth Obermayer, C. Whalen, Tatum Spagnoletti, Wenjie Luo, H. Liu, Rosanna Hok, Carol Aghajanian, David B. Solit, Gordon B. Mills, Barry S. Taylor, Helen Won, Michael F. Berger, Sangeetha Palakurthi, J. Liu, Lewis C. Cantley, EP Winer
出版 2016Artigo -
2
Translational Breast Cancer Research Consortium (TBCRC) 022: A Phase II Trial of Neratinib for Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Bra... 由 Rachel A. Freedman, Rebecca Gelman, Jeffrey S. Wefel, Michelle Melisko, Kenneth R. Hess, Roisín M. Connolly, Catherine Van Poznak, Polly Niravath, Shannon L. Puhalla, Nuhad K. Ibrahim, Kimberly Blackwell, Beverly Moy, Christina I. Herold, Minetta C. Liu, Alarice Lowe, Nathalie Y.R. Agar, Nicole Ryabin, Sarah Farooq, Elizabeth Lawler, Mothaffar F. Rimawi, Ian E. Krop, Antonio C. Wolff, Eric P. Winer, Nancy U. Lin
出版 2016Artigo -
3
Olaparib and α-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial 由 Panagiotis A. Konstantinopoulos, William T. Barry, Michael J. Birrer, Shannon N. Westin, Karen A. Cadoo, Geoffrey I. Shapiro, Erica L. Mayer, Roisin E. O’Cearbhaill, Robert L. Coleman, Bose Kochupurakkal, Christin Whalen, Jennifer Curtis, Sarah Farooq, Weixiu Luo, Julia Eismann, Mary K. Buss, Carol Aghajanian, Gordon B. Mills, Sangeetha Palakurthi, Paul T. Kirschmeier, Joyce F. Liu, Lewis C. Cantley, Scott H. Kaufmann, Elizabeth M. Swisher, Alan D. D’Andrea, Eric P. Winer, Gerburg M. Wulf, Ursula A. Matulonis
出版 2019Artigo
相關主題
Breast cancer
Cancer
Internal medicine
Medicine
Oncology
BRCA mutation
Biochemistry
Gene
Olaparib
Ovarian cancer
PARP inhibitor
Poly ADP ribose polymerase
Polymerase
Biology
Chemistry
Clinical endpoint
Clinical trial
Fallopian tube cancer
Gastroenterology
Lapatinib
Metastatic breast cancer
Neratinib
Pharmacokinetics
Pharmacology
Phases of clinical research
Radiation therapy
Radiosurgery
Response Evaluation Criteria in Solid Tumors
Trastuzumab